当秤量下降时:在帕金森病中减肥的途径和未来的方向
Ellie D Gabriel1, Robert S Eisinger1, Joyce M Lee1
1Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
概括
帕金森病 (PD) 通常涉及不明原因的体重减轻,影响患者的健康. 本综述探讨了影响PD体重变化的代谢,神经内分泌和治疗因素,旨在指导未来的治疗方法.
科学领域:
- 神经学 神经学
- 代谢障碍 代谢障碍 代谢障碍
- 神经退行性疾病 神经退行性疾病
背景情况:
- 帕金森病 (PD) 的特点是运动症状,但体重减轻等非运动症状显著影响疾病的进展.
- 在PD中减肥背后的机制尚未完全理解,这限制了有效的治疗选择.
- 减肥是神经退行性疾病中公认的问题,需要进一步调查.
研究的目的:
- 审查目前关于帕金森病体重变化的证据.
- 探索导致PD中减肥的潜在机制.
- 讨论PD患者体重管理的临床因素,治疗方法和潜在的治疗策略.
主要方法:
- 本综述综合了有关帕金森病体重的现有研究.
- 它检查了流行病学趋势,建议的机制和临床/治疗因素.
- 还考虑了来自深度大脑刺激研究的见解.
主要成果:
- 体重减轻是PD中显著的非运动性症状,对发病率和死亡率有影响.
- 代谢调节,神经内分泌信号,认知衰退和胃肠道问题都与PD体重变化有关.
- 深度大脑刺激也可能影响体重轨迹.
结论:
- 了解PD中减肥的多方面的机制对于开发有针对性的干预措施至关重要.
- 需要进一步的研究来解决知识差距,并将研究结果转化为实际的治疗策略.
- 解决体重管理对于改善帕金森病患者的整体健康和结果至关重要.
关键词:
DBS; 帕金森病; 体重 体重相关概念视频
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
259
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259
Pathophysiology of Diabetes
4.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.0K
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Neural Regulation
43.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K


